Stock CVKD CADRENAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Market Closed - Nasdaq
Other stock markets
 01:30:00 29/06/2024 am IST 		5-day change 1st Jan Change
0.47 USD +3.21% Intraday chart for Cadrenal Therapeutics, Inc. +4.03% -36.48%
09/05 Cadrenal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
09/04 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts CI
e6647298dc5f9fcc2cfd0eca3c5bb68.3nGkfUAyDjqo5nCfOQtC7wxCctNZYS40Rmzl-Xqjcjs.kzrVHhhRPAnmrjbPD1sDl1l0MZ5hE0dNJwmflyuTPmHnJM8rcW0_QNzRRA~cbc2f386a35fdd51b4a36a04c04795fd
  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Charts Cadrenal Therapeutics, Inc.
  5. News Chart